406 related articles for article (PubMed ID: 8232223)
1. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
Selley DE; Breivogel CS; Childers SR
Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
[TBL] [Abstract][Full Text] [Related]
2. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
3. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
Costa T; Klinz FJ; Vachon L; Herz A
Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.
Costa T; Lang J; Gless C; Herz A
Mol Pharmacol; 1990 Mar; 37(3):383-94. PubMed ID: 2156152
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
6. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
7. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.
Remmers AE; Clark MJ; Liu XY; Medzihradsky F
J Pharmacol Exp Ther; 1998 Nov; 287(2):625-32. PubMed ID: 9808689
[TBL] [Abstract][Full Text] [Related]
8. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
[TBL] [Abstract][Full Text] [Related]
9. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
Prather PL; Loh HH; Law PY
Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
[TBL] [Abstract][Full Text] [Related]
10. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
Yabaluri N; Medzihradsky F
Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
[TBL] [Abstract][Full Text] [Related]
11. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
[TBL] [Abstract][Full Text] [Related]
12. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
Werling LL; Puttfarcken PS; Cox BM
Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
[TBL] [Abstract][Full Text] [Related]
13. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
Szekeres PG; Traynor JR
J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
[TBL] [Abstract][Full Text] [Related]
14. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma x glioma (NG108-15) hybrid cells chronically exposed to an opioid.
Ammer H; Schulz R
Mol Pharmacol; 1993 Apr; 43(4):556-63. PubMed ID: 8386308
[TBL] [Abstract][Full Text] [Related]
15. Opioid inhibition of adenylyl cyclase in membranes from pertussis toxin-treated NG108-15 cells.
Selley DE; Breivogel CS; Childers SR
J Recept Signal Transduct Res; 1998 Jan; 18(1):25-49. PubMed ID: 9493566
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
Selley DE; Liu Q; Childers SR
J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589
[TBL] [Abstract][Full Text] [Related]
17. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells.
Vachon L; Costa T; Herz A
Mol Pharmacol; 1987 Feb; 31(2):159-68. PubMed ID: 3027528
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptor-mediated inhibition of GDP-activated adenylyl cyclase suggests a direct interaction of inhibitory guanine nucleotide-binding proteins and adenylyl cyclase.
Niroomand F; Bangert M; Philipps C; Rauch B
Mol Pharmacol; 1993 Jan; 43(1):90-5. PubMed ID: 8380886
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the 5-hydroxytryptamine-1A receptor-mediated activation of high-affinity GTP hydrolysis in rat hippocampal membranes.
Odagaki Y; Fuxe K
J Pharmacol Exp Ther; 1995 Jul; 274(1):337-44. PubMed ID: 7616417
[TBL] [Abstract][Full Text] [Related]
20. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
Bidlack JM; O'Malley WE; Schulz R
Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
